Usted buscó: mast cell (Inglés - Danés)

mast cell
mastceller

mast cell tumours are cancerous proliferations of mast cells.
mastcelletumorer er cancerformeringer af mastceller.

masivet is a prescription medicine used to treat dog mast cell tumours.
masivet er et receptpligtigt lægemiddel, som anvendes til behandling af mastcelletumorer hos hunde.

in certain circumstances, mast cell tumours can be life threatening for your dog.
under visse omstændigheder kan mastcelletumorer være livstruende for din hund.

the main study was carried out in two phases in 151 dogs with mast cell tumours.
hovedundersøgelsen blev udført i to faser på 151 hunde med mastcelletumorer.

canine mast cell tumour growth is frequently driven by an activating mutation in c-kit.
mastcelletumorvækst hos hunde er ofte drevet af en aktiverende mutation i c-kit.

there was no evidence of an anaphylactic response due to mast-cell degranulation in cynomolgus monkeys.
der var ikke tegn på et anafylaktisk respons på grund af mastcelledegranulering i cynomolgusaber.

palladia is used to treat dogs with mast-cell tumours (a type of skin cancer).
palladia anvendes til at behandle mast-celletumorer hos hunde (en form for hudkræft).

if gastrointestinal ulceration is suspected, whether or not due to palladia or to mast cell tumour degranulation, stop the administration of palladia and treat appropriately.
administration af palladia skal ophøre og passende behandling iværksættes, hvis der er mistanke om gastrointestinal ulceration, uanset om det skyldes palladia eller degranulering af mastcelletumordegranuleringer.

the study included dogs of various breeds and both sexes with mast-cell tumours that had come back after surgery or could not be removed with surgery.
undersøgelsen omfattede hunde af forskellige racer og af begge køn med mastcelletumorer, som var vendt tilbage efter kirurgi, eller som ikke kunne fjernes med kirurgi.

masitinib treatment should only be used in dogs with non-resectable mast cell tumours and which express the mutated c-kit tyrosine kinase receptor.
behandling med mastinib bør kun anvendes til hunde med ikke-resektable mastcelletumorer, og som eksprimerer den muterede c-kit tyrosinkinasereceptor.

tacrolimus has also been shown to inhibit the release of inflammatory mediators from skin mast cells, basophils and eosinophils.
tacrolimus er også vist at hæmme frigørelse af inflammations mediatorer fra hudmastceller og fra basofile og eosinofile leukocyter.

data from in vitro studies suggest that it may act on human conjunctival mast cells to inhibit the release of pro-inflammatory mediators.
data fra in vitro forsøg antyder, at olopatadin kan virke på humane conjunktivale mastceller og dermed hæmme frigivelsen af pro- inflammatoriske mediatorer.

masivet is for the treatment of dogs with non-resectable mast cell tumours (grade 2 or 3) with a confirmed mutated c-kit tyrosine kinase receptor.
masivet er beregnet til behandling af hunde med ikke-resektable mastcelletumorer (grad 2 eller 3) med en bekræftet muteret c-kit tyrosinkinasereceptor.

these include inhibiting the release of proinflammatory cytokines such as il-4, il-6, il-8, and il-13 from human mast cells/basophils, as well as inhibition of the expression of the adhesion molecule p-selectin on endothelial cells.
disse omfatter hæmning af frigørelsen af proinflammatoriske cytokiner såsom il-4, il-6, il-8 og il-13 fra humane mastceller/basofile, og ligeledes hæmning af ekspressionen af adhæsionsmolekylet p-selectin på endothelceller.